C
CORT icon

Covestor’s Corcept Therapeutics CORT Stock Holding History

Covestor’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12K Buy
139
+13
+10% +$785 0.01% 1418
2026
Q1 		$5K Sell
126
-90
-42% -$3.37K ﹤0.01% 1786
2025
Q4 		$8K Sell
216
-1
-0.5% -$79 ﹤0.01% 1690
2025
Q3 		$18K Buy
217
+2
+0.9% +$145 0.01% 1306
2025
Q2 		$16K Sell
215
-411
-66% -$29.8K 0.01% 1326
2025
Q1 		$72K Buy
626
+592
+1,741% +$36K 0.05% 675
2024
Q4 		$2K Sell
34
-309
-90% -$16.2K ﹤0.01% 1854
2024
Q3 		$16K Buy
343
+17
+5% +$604 0.01% 1294
2024
Q2 		$10K Sell
326
-4,683
-93% -$128K 0.01% 1523
2024
Q1 		$126K Buy
5,009
+1,217
+32% +$28.8K 0.08% 376
2023
Q4 		$123K Sell
3,792
-1,076
-22% -$29.5K 0.08% 364
2023
Q3 		$133K Sell
4,868
-51
-1% -$1.48K 0.1% 271
2023
Q2 		$109K Buy
4,919
+2,980
+154% +$68.6K 0.08% 384
2023
Q1 		$42K Buy
1,939
+468
+32% +$10.3K 0.04% 772
2022
Q4 		$30K Sell
1,471
-3
-0.2% -$75 0.02% 910
2022
Q3 		$38K Buy
1,474
+1,449
+5,796% +$38.8K 0.03% 799
2022
Q2 		$1K Sell
25
-81
-76% -$1.76K ﹤0.01% 1692
2022
Q1 		$2K Buy
106
+36
+51% +$766 ﹤0.01% 1663
2021
Q4 		$1K Buy
+70
New +$1.42K ﹤0.01% 1693

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Covestor's CORT Position: Q2 2026 in Review

Covestor increased its Corcept Therapeutics (CORT) stake by 10% in Q2 2026, buying an estimated $785 and bringing the position to 139 shares worth $12K. The position accounts for 0.01% of the portfolio, ranked #1418.

Covestor first reported a position in CORT in Q4 2021 and has held it in 19 quarters since. The position peaked at $133K in Q3 2023. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Covestor held 139 shares of Corcept Therapeutics worth $12K as of Q2 2026.
  • Covestor bought 13 Corcept Therapeutics shares in Q2 2026, an estimated $785.
  • Corcept Therapeutics made up 0.01% of Covestor's portfolio in Q2 2026, its #1418 holding.
  • Covestor first reported a position in Corcept Therapeutics in Q4 2021 and has held it in 19 quarters since.
  • Covestor's Corcept Therapeutics position peaked at $133K in Q3 2023.
  • 422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.